ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Ophthalmology

Top Ophthalmology Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALAN SOLINSKY M.D.

Ophthalmology

5,767

$752K

925
768 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

85%
prescriptions for brand name drugs

Avg: 66%

$130
Average prescription price

Avg: $91

DAVID HILL M.D.

Ophthalmology

4,420

$436K

716
666 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

65%
prescriptions for brand name drugs

Avg: 66%

$99
Average prescription price

Avg: $91

GEOFFREY EMERICK MD

Ophthalmology

4,228

$397K

678
619 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

68%
prescriptions for brand name drugs

Avg: 66%

$94
Average prescription price

Avg: $91

PETER BRANDEN M.D.

Ophthalmology

4,061

$285K

574
549 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 66%

$70
Average prescription price

Avg: $91

JAMES PASTERNACK M.D.

Ophthalmology

4,052

$444K

647
602 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 66%

$110
Average prescription price

Avg: $91

JAMES MARTONE MD

Ophthalmology

4,049

$447K

554
513 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

66%
prescriptions for brand name drugs

Avg: 66%

$110
Average prescription price

Avg: $91

JAMES DEAN MD

Ophthalmology

3,850

$369K

713
661 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

80%
prescriptions for brand name drugs

Avg: 66%

$96
Average prescription price

Avg: $91

MARTIN WAND M.D.

Ophthalmology

3,800

$359K

544
497 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

61%
prescriptions for brand name drugs

Avg: 66%

$94
Average prescription price

Avg: $91

STANLEY HERSH M.D.

Ophthalmology

3,682

$322K

478
455 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 66%

$88
Average prescription price

Avg: $91

C. GILBERT M.D.

Ophthalmology

3,504

$273K

688
638 are 65+

22%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 66%

$78
Average prescription price

Avg: $91

MARTIN SEREMET M.D.

Ophthalmology

3,490

$355K

613
562 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

83%
prescriptions for brand name drugs

Avg: 66%

$102
Average prescription price

Avg: $91

BRUCE ALTMAN M.D.

Ophthalmology

3,264

$282K

497
473 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 66%

$86
Average prescription price

Avg: $91

DELIA MANJONEY MD

Ophthalmology

3,254

$286K

553
538 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 66%

$88
Average prescription price

Avg: $91

EDMUND SUSKI MD

Ophthalmology

2,929

$202K

519
499 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 66%

$69
Average prescription price

Avg: $91

SCOTT DOLIN MD

Ophthalmology

2,785

$274K

480
451 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

65%
prescriptions for brand name drugs

Avg: 66%

$98
Average prescription price

Avg: $91

MARY GINA RATCHFORD M.D.

Ophthalmology

2,753

$297K

596
555 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 66%

$108
Average prescription price

Avg: $91

RICHARD CARLTON M.D.

Ophthalmology

2,732

$263K

620
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 66%

$96
Average prescription price

Avg: $91

DONALD SALZBERG MD

Ophthalmology

2,713

$357K

493
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

86%
prescriptions for brand name drugs

Avg: 66%

$132
Average prescription price

Avg: $91

JAMES WONG M.D.

Ophthalmology

2,488

$274K

526
505 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

67%
prescriptions for brand name drugs

Avg: 66%

$110
Average prescription price

Avg: $91

CHRISTOPHER TENG MD

Ophthalmology

2,395

$227K

351
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

69%
prescriptions for brand name drugs

Avg: 66%

$95
Average prescription price

Avg: $91

JEFFREY HERTZ MD

Ophthalmology

2,349

$229K

443
401 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

70%
prescriptions for brand name drugs

Avg: 66%

$97
Average prescription price

Avg: $91

THOMAS BEGGINS M.D.

Ophthalmology

2,270

$189K

514
469 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

71%
prescriptions for brand name drugs

Avg: 66%

$83
Average prescription price

Avg: $91

PRIOR PARKER MD

Ophthalmology

2,235

$181K

364
347 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

64%
prescriptions for brand name drugs

Avg: 66%

$81
Average prescription price

Avg: $91

MARK MILNER MD

Ophthalmology

2,223

$274K

443
380 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

72%
prescriptions for brand name drugs

Avg: 66%

$123
Average prescription price

Avg: $91

ANISH SHAH MD

Ophthalmology

2,155

$293K

415
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

74%
prescriptions for brand name drugs

Avg: 66%

$136
Average prescription price

Avg: $91

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank